MENU
+Compare
MED
Stock ticker: NYSE
AS OF
Sep 15, 04:59 PM (EDT)
Price
$14.20
Change
+$0.23 (+1.65%)
Capitalization
153.55M

MED Medifast Forecast, Technical & Fundamental Analysis

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life... Show more

MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for MED with price predictions
Sep 12, 2025

MED's RSI Oscillator ascending out of oversold territory

The RSI Indicator for MED moved out of oversold territory on August 08, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 50 similar instances when the indicator left oversold territory. In of the 50 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for MED just turned positive on September 12, 2025. Looking at past instances where MED's MACD turned positive, the stock continued to rise in of 54 cases over the following month. The odds of a continued upward trend are .

MED moved above its 50-day moving average on September 12, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MED advanced for three days, in of 272 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 51 cases where MED's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on September 05, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on MED as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The 10-day moving average for MED crossed bearishly below the 50-day moving average on September 08, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MED declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MED broke above its upper Bollinger Band on August 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MED entered a downward trend on August 14, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.711) is normal, around the industry mean (9.382). MED has a moderately high P/E Ratio (42.333) as compared to the industry average of (20.729). MED's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.630). MED has a moderately high Dividend Yield (0.089) as compared to the industry average of (0.042). P/S Ratio (0.320) is also within normal values, averaging (636.281).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MED’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MED’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

View a ticker or compare two or three
MED
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

MED is expected to report earnings to fall 236.36% to -30 cents per share on November 10

Medifast MED Stock Earnings Reports
Q3'25
Est.
$-0.30
Q2'25
Beat
by $0.44
Q1'25
Beat
by $0.12
Q4'24
Beat
by $0.24
Q3'24
Beat
by $0.63
The last earnings report on August 04 showed earnings per share of 21 cents, beating the estimate of -21 cents. With 38.10K shares outstanding, the current market capitalization sits at 153.55M.
A.I.Advisor
published Dividends

MED paid dividends on November 07, 2023

Medifast MED Stock Dividends
А dividend of $1.65 per share was paid with a record date of November 07, 2023, and an ex-dividend date of September 18, 2023. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of health and diet products

Industry PersonnelServices

Profile
Fundamentals
Details
Industry
Specialty Stores
Address
100 International Drive
Phone
+1 410 581-8042
Employees
634
Web
https://www.medifastinc.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VLERF5.300.11
+2.17%
Valeura Energy Inc.
PIFMY24.450.25
+1.03%
PT Indofood Sukses Makmur TBK
BPXXY21.91N/A
N/A
BPER BANCA S.P.A
ANORF0.02N/A
N/A
ANORTECH INC
NRXBF0.63-0.01
-0.85%
NUREXONE BIOLOGIC INC

MED and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MED has been loosely correlated with EXPE. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if MED jumps, then EXPE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
+0.36%
EXPE - MED
36%
Loosely correlated
+0.37%
CSV - MED
31%
Poorly correlated
-0.12%
TNL - MED
23%
Poorly correlated
-1.33%
MCW - MED
23%
Poorly correlated
-1.99%
HRB - MED
22%
Poorly correlated
-1.75%
More

Groups containing MED

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MED
1D Price
Change %
MED100%
+0.36%
Commercial Services
category (190 stocks)
19%
Poorly correlated
-0.25%
Personnel Services
category (23 stocks)
13%
Poorly correlated
-1.39%